IMDX

INSIGHT MOLECULAR DIA INC

IMDX·68235C206·US·Common Stock·Healthcare - Diagnostics & Research-Activist

IMDX (INSIGHT MOLECULAR DIA INC) is held by 24 institutional investors as of Q1 2026. Largest holders: Alyeska Investment Group, L.P. ($2.8M), VANGUARD CAPITAL MANAGEMENT LLC ($1.8M), GEODE CAPITAL MANAGEMENT, LLC ($860,170). Net institutional sentiment: Mixed.

24
Holders
Avg rating(6 Elite)
$7.8M
Total Value
64% (30)
Fund Consensus
18 buying - 10 selling
IMDXSmart Money Verdict
View all
Held by 24 funds
6 elite
Who's Trading
InsiderBLBROADWOOD PARTNERS, L.P.Buy $913KApr 27, 2026
InsiderBLBROADWOOD PARTNERS, L.P.BuyApr 27, 2026
ActivistBRBroadwood Partners, L.P.39.7%Apr 27, 2026
InsiderBLBROADWOOD PARTNERS, L.P.Buy $137KApr 24, 2026
InsiderBLBROADWOOD PARTNERS, L.P.BuyApr 24, 2026
InsiderBLBROADWOOD PARTNERS, L.P.Buy $982KApr 23, 2026
InsiderBLBROADWOOD PARTNERS, L.P.BuyApr 23, 2026
InsiderBLBROADWOOD PARTNERS, L.P.BuyApr 20, 2026
InsiderBLBROADWOOD PARTNERS, L.P.Buy $158KApr 20, 2026
ActivistAIAWM Investment Company, Inc.10.0%May 9, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
840,777$2.8M0.0%-6.79%
36
New
537,161$1.8M0.0%-6.79%
39
Increased
262,053(+13.5%)$860,1700.0%+34.10%
28
Increased
135,345(+3.0%)$443,9320.0%+25.61%
17
New
132,591$434,8980.0%-6.79%
33
Increased
103,470(+68.6%)$339,3820.0%+23.00%
35
Decreased
56,093(-22.6%)$183,9850.0%-27.43%
0
Increased
50,754(+6.3%)$166,4730.0%+43.21%
16
Increased
49,090(+0.5%)$161,0150.0%+16.49%
15
Increased
36,088(+0.5%)$118,3690.0%+71.38%
15
New
30,353$99,5580.0%-6.79%
30
Decreased
25,230(-11.0%)$82,7540.0%-27.43%
0
Decreased
24,135$79,1620.0%-3.15%
0
Increased
22,751(+673.6%)$74,6240.0%-2.02%
23
New
18,253$59,8700.0%-6.79%
29
New
12,250$40,1800.0%-6.79%
28
Decreased
10,500(-59.9%)$34,4400.0%-27.43%
0
Unchanged
10,416$34,1640.0%+57.28%
0
New
5,775$18,9420.0%-6.79%
28
Increased
815(+814x)$2,6730.0%-6.82%
14

Showing 1-20 of 30

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used